Cita APA (7a ed.)
Voloshyna, I., Seshadri, S., Anwar, K., Littlefield, M. J., Belilos, E., Carsons, S. E., & Reiss, A. B. (2014). Infliximab Reverses Suppression of Cholesterol Efflux Proteins by TNF- [alpha]: A Possible Mechanism for Modulation of Atherogenesis. BioMed Research International, 2014, 312647-312648.
Cita Chicago Style (17a ed.)
Voloshyna, Iryna, Sangeetha Seshadri, Kamran Anwar, Michael J. Littlefield, Elise Belilos, Steven E. Carsons, y Allison B. Reiss. "Infliximab Reverses Suppression of Cholesterol Efflux Proteins by TNF- [alpha]: A Possible Mechanism for Modulation of Atherogenesis." BioMed Research International 2014 (2014): 312647-312648.
Cita MLA (9a ed.)
Voloshyna, Iryna, et al. "Infliximab Reverses Suppression of Cholesterol Efflux Proteins by TNF- [alpha]: A Possible Mechanism for Modulation of Atherogenesis." BioMed Research International, vol. 2014, 2014, pp. 312647-312648.
Precaución: Estas citas no son 100% exactas.